
AI risk alerts, new biomarkers and expanded screening are landing on primary care physicians without added time or staff. Shifting outreach, testing coordination and closed-loop referrals to partners can help practices close the gap.

Conrad Gudmundson is chief commercial officer at Lucem Health, where he leads the company’s business development and strategic partnership efforts to advance earlier disease detection.

AI risk alerts, new biomarkers and expanded screening are landing on primary care physicians without added time or staff. Shifting outreach, testing coordination and closed-loop referrals to partners can help practices close the gap.